Search Result

Join Crystal Pharmatech for the Sino-American Pharmaceutical Professionals Association (SAPA) NE 26th Annual Conference Join our team for the Sino-American Pharmaceutical Professionals Association (SAPA) NE 26th Annual Conference in Cambridge, MA on Saturday (6/8).
Amorphous Solid Dispersion Technology and the Service Advantages of Crystal Pharmaceutical With the rapid development of biopharmaceutical technology, the field of small molecule drug discovery continues to achieve significant breakthroughs. In this context, pharmaceutical formulations play...
Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder and Chief Scientific Officer Cranbury, New Jersey, January 17, 2024 - Crystal Bio, a key division of Crystal Pharmatech, is excited to announce Dr. Shiaw-Lin (Billy) Wu as its new co-founder and Chief Scientific Officer (CSO). Dr...
Sterility Assays in Drug/Device Manufacturing
Crystal Pharmatech will be in San Diego from June 3-6 at BIO International Convention Crystal Pharmatech senior leadership will be in San Diego from June 3-6 at BIO International Convention to discuss the latest in drug development.
ASD Column | Mastering Stable Art: Unveiling Key Factors Influencing Physical Stability of Amorphous Solid Dispersions / Formulation Rightthe First Time /In recent years, amorphous solid dispersions (ASD) have attracted attention due to their ability to significantly improve the solubility of poorly soluble drugs. Sin...
Meet Crystal Pharmatech at Chinese Antibody Society 2024 Annual Conference Join our team in Boston on Saturday for the Chinese Antibody Society 2024 Annual Conference.Catch up with Crystal Bio's CSO, Billy Wu, Ph.D., and our new CTO, Ye Gu, Ph.D. We will also be joined b...
Crystal Bio Appoints Dr. Ye Gu as Co-founder, CTO, and Head of USA BD Cranbury, NJ, May 14, 2024 – Crystal Bio, an innovative biologics analytical division of Crystal Pharmatech, is delighted to announce the appointment of Dr. Ye Gu as Co-founder, Chief Technology Officer, and Head of USA Business Development. Dr. Gu brings over 16 years of distinguished experience in biologics R&D and a robust track record of leadership in the biotechnology industry.
How to Mitigate Disproportionation of API Salts in Pharmaceutical Formulations
ASD Column | How to Select Polymers in Hot-melt Extrusion Process? Hot melt extrusion (HME) technology is widely used in the development of amorphous solid dispersions (ASD) due to its advantages such as solvent-free processing, continuous manufacturing, high automat...
Development and Production Application Cases of Amorphous Solid Dispersion Formulations (I) - Hot Melt Extrusion
Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit Recently, Crystal Formulations Services (CFS), the CDMO Business Unit of Crystal Pharmatech has achieved a significant milestone by successfully passing the on-site audit conducted by the European Qua...
Meet Crystal Pharmatech at 15th Drug Discovery Strategic Summit (DDSS) Accelerated development from discovery to the clinic. Catch up with Ridwan Islam, M. Pharm., Ph.D. in Boston from May 8-9 at the 15th Drug Discovery Strategic Summit.Date: May 8-9, 2024Location: Emba...
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation Cranbury, New Jersey, USA – May 9, 2025 – Crystal Pharmatech Inc. Crystal Pharmatech and Divamics Inc. Divamics today announced a strategic collaboration to integrate AI-aided...
ASD Column | Understanding the ASD Preparation Methods and Selecting the Optimal Method for Solution In the previous article Mastering the Art of Stability, we revealed the key factors influencing the physical stability of amorphous solid dispersions (ASDs) and recognized that choosing th...